Novel platinum II and platinum IV complexes exhibit potent cytotoxicity and selectivity towards several cancer cell lines

The discovery of cisplatin and its antineoplastic potential directed research toward the usage of platinum-based complexes as chemotherapeutical drugs. The aim of the present study is to test the anticancer activity of two novel platinum complexes Pt(II) and Pt(IV) on lung cancer cells (A549), breas...

Full description

Saved in:
Bibliographic Details
Main Author: Elias, Elias (author)
Format: masterThesis
Published: 2020
Subjects:
Online Access:http://hdl.handle.net/10725/13850
https://doi.org/10.26756/th.2022.376
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513468322807808
author Elias, Elias
author_facet Elias, Elias
author_role author
dc.creator.none.fl_str_mv Elias, Elias
dc.date.none.fl_str_mv 2020
2020-05-14
2022-07-21T10:38:10Z
2022-07-21T10:38:10Z
dc.identifier.none.fl_str_mv http://hdl.handle.net/10725/13850
https://doi.org/10.26756/th.2022.376
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php
dc.language.none.fl_str_mv en
dc.publisher.none.fl_str_mv Lebanese American University
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Platinum compounds -- Therapeutic use
Cancer -- Chemotherapy
Cell lines
Lebanese American University -- Dissertations
Dissertations, Academic
dc.title.none.fl_str_mv Novel platinum II and platinum IV complexes exhibit potent cytotoxicity and selectivity towards several cancer cell lines
dc.type.none.fl_str_mv Thesis
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/masterThesis
description The discovery of cisplatin and its antineoplastic potential directed research toward the usage of platinum-based complexes as chemotherapeutical drugs. The aim of the present study is to test the anticancer activity of two novel platinum complexes Pt(II) and Pt(IV) on lung cancer cells (A549), breast cancer cells (MDA-MB-231), melanoma cells (A375), and mesenchymal stem cells (MSC), and evaluate the mechanism of action involved. Cell viability was assessed 72 hours post-treatment using MTS assay. The cellular uptake of both compounds was measured by ICP-MS. Their effect on DNA fragmentation was then tested using Comet assay. The type of cell death was assessed by flow cytometry. Evaluation of apoptotic proteins’ expression was performed using western blots. Results showed that both complexes significantly reduced cancer cell viability and exhibited 7 to 20-fold higher cytotoxicity compared to cisplatin. Pt(IV) showed remarkable selectivity towards different cancer cells (17-22 fold) compared with mesenchymal stem cells. While both complexes were actively transported into the cells, Pt(II) showed a faster and higher uptake compared to its platinum IV analogue. Pt(IV) but not Pt(II) treatment caused significant DNA fragmentation in A549 cells. Western blot analysis demonstrated an upregulation of Bax/Bcl-2 ratio and cytochrome c, downregulation of procaspases 3 and 9 and cleavage of Parp for both Pt(II) and Pt(IV), which indicates that apoptosis was induced through the intrinsic pathway. No effect on procaspase 8 was observed, eliminating the involvement of the extrinsic apoptotic pathway. Flow cytometry analysis confirmed the apoptotic cell death caused by both platinum complexes. In conclusion, Pt(II) and Pt(IV) may be considered as promising anti-cancer drugs with Pt(IV) being more selective to cancer cells, which might provide a robust alternative for currently approved anticancer platinum medications.
eu_rights_str_mv openAccess
format masterThesis
id LAURepo_9f853b32d33f07d1b6dc4e66cda6fd34
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/13850
publishDate 2020
publisher.none.fl_str_mv Lebanese American University
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Novel platinum II and platinum IV complexes exhibit potent cytotoxicity and selectivity towards several cancer cell linesElias, EliasPlatinum compounds -- Therapeutic useCancer -- ChemotherapyCell linesLebanese American University -- DissertationsDissertations, AcademicThe discovery of cisplatin and its antineoplastic potential directed research toward the usage of platinum-based complexes as chemotherapeutical drugs. The aim of the present study is to test the anticancer activity of two novel platinum complexes Pt(II) and Pt(IV) on lung cancer cells (A549), breast cancer cells (MDA-MB-231), melanoma cells (A375), and mesenchymal stem cells (MSC), and evaluate the mechanism of action involved. Cell viability was assessed 72 hours post-treatment using MTS assay. The cellular uptake of both compounds was measured by ICP-MS. Their effect on DNA fragmentation was then tested using Comet assay. The type of cell death was assessed by flow cytometry. Evaluation of apoptotic proteins’ expression was performed using western blots. Results showed that both complexes significantly reduced cancer cell viability and exhibited 7 to 20-fold higher cytotoxicity compared to cisplatin. Pt(IV) showed remarkable selectivity towards different cancer cells (17-22 fold) compared with mesenchymal stem cells. While both complexes were actively transported into the cells, Pt(II) showed a faster and higher uptake compared to its platinum IV analogue. Pt(IV) but not Pt(II) treatment caused significant DNA fragmentation in A549 cells. Western blot analysis demonstrated an upregulation of Bax/Bcl-2 ratio and cytochrome c, downregulation of procaspases 3 and 9 and cleavage of Parp for both Pt(II) and Pt(IV), which indicates that apoptosis was induced through the intrinsic pathway. No effect on procaspase 8 was observed, eliminating the involvement of the extrinsic apoptotic pathway. Flow cytometry analysis confirmed the apoptotic cell death caused by both platinum complexes. In conclusion, Pt(II) and Pt(IV) may be considered as promising anti-cancer drugs with Pt(IV) being more selective to cancer cells, which might provide a robust alternative for currently approved anticancer platinum medications.1 online resource (xvi, 80 leaves): ill. (some col.)Includes bibliographical references (leaf 55-73).Lebanese American University2022-07-21T10:38:10Z2022-07-21T10:38:10Z20202020-05-14Thesisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesishttp://hdl.handle.net/10725/13850https://doi.org/10.26756/th.2022.376http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.phpeninfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/138502022-07-21T10:39:35Z
spellingShingle Novel platinum II and platinum IV complexes exhibit potent cytotoxicity and selectivity towards several cancer cell lines
Elias, Elias
Platinum compounds -- Therapeutic use
Cancer -- Chemotherapy
Cell lines
Lebanese American University -- Dissertations
Dissertations, Academic
status_str publishedVersion
title Novel platinum II and platinum IV complexes exhibit potent cytotoxicity and selectivity towards several cancer cell lines
title_full Novel platinum II and platinum IV complexes exhibit potent cytotoxicity and selectivity towards several cancer cell lines
title_fullStr Novel platinum II and platinum IV complexes exhibit potent cytotoxicity and selectivity towards several cancer cell lines
title_full_unstemmed Novel platinum II and platinum IV complexes exhibit potent cytotoxicity and selectivity towards several cancer cell lines
title_short Novel platinum II and platinum IV complexes exhibit potent cytotoxicity and selectivity towards several cancer cell lines
title_sort Novel platinum II and platinum IV complexes exhibit potent cytotoxicity and selectivity towards several cancer cell lines
topic Platinum compounds -- Therapeutic use
Cancer -- Chemotherapy
Cell lines
Lebanese American University -- Dissertations
Dissertations, Academic
url http://hdl.handle.net/10725/13850
https://doi.org/10.26756/th.2022.376
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php